The final approval from the United States Food and Drug Administration is to market Lansoprazole delayed release orally disintegrating tablets in the strengths of 15 mg and 30 mg.from Moneycontrol Business News https://ift.tt/2Sjzi4S
The final approval from the United States Food and Drug Administration is to market Lansoprazole delayed release orally disintegrating tablets in the strengths of 15 mg and 30 mg.
Comments
Post a Comment